CJC-1295, a growth hormone-releasing hormone analog, extends GH release duration, maximizing its benefits
TB-500 is a systemic recovery peptide: a synthetic fragment of Thymosin Beta-4, it circulates throughout the body to reduce inflammation, improve cell migration, and support recovery across multiple tissue types simultaneously
This supplement is not intended to diagnose, treat, cure, or prevent any disease
Research has demonstrated sustained growth hormone release following administration: Enhanced binding affinity to GHRH receptors compared to native GHRH Increased resistance to dipeptidyl peptidase-IV enzymatic degradation Sustained elevation of plasma growth hormone concentrations for several hours post-administration Dose-dependent increases in both growth hormone and IGF-1 levels Studies have shown that CJC-1295 increases plasma growth hormone levels by 2- to 10-fold for up to 6 days, with IGF-1 levels remaining elevated for 9-11 days following a single dose in human subjects
Circulation and nitric oxide Ozone-related redox signaling may influence endothelial and nitric-oxide pathways that affect renal blood flow